211 related articles for article (PubMed ID: 6153283)
41. Reduction in excessive muscle tone by selective depletion of serotonin in intercollicularly decerebrated rats.
Sakai M; Matsunaga M; Kubota A; Yamanishi Y; Nishizawa Y
Brain Res; 2000 Mar; 860(1-2):104-11. PubMed ID: 10727628
[TBL] [Abstract][Full Text] [Related]
42. Effects of 5,7-dihydroxytryptamine and 6-hydroxydopamine on head-twitch response induced by serotonin, p-chloroamphetamine, and tryptamine in mice.
Orikasa S; Sloley BD
Psychopharmacology (Berl); 1988; 95(1):124-31. PubMed ID: 3133691
[TBL] [Abstract][Full Text] [Related]
43. A general role for serotonin in the control of behavior: studies with intracerebral 5,7-dihydroxytryptamine.
Vanderwolf CH
Brain Res; 1989 Dec; 504(2):192-8. PubMed ID: 2598022
[TBL] [Abstract][Full Text] [Related]
44. Failure to produce blood pressure changes following pharmacological or surgical depletion of brain serotonin in the spontaneously hypertensive rat.
Browning RA; Bramlet DG; Myers JH; Bundman MC; Smith ML
Clin Exp Hypertens (1978); 1981; 3(5):953-73. PubMed ID: 6456876
[TBL] [Abstract][Full Text] [Related]
45. Increased behavioural response to intrathecal serotonin after lesion of serotonergic pathways with 5,7-dihydroxytryptamine seems not to be due to depletion of serotonin.
Eide PK; Hole K
Acta Physiol Scand; 1988 Oct; 134(2):291-4. PubMed ID: 2976239
[TBL] [Abstract][Full Text] [Related]
46. Amphetamine and LSD as discriminative stimuli: alterations following neonatal monoamine reductions.
Minnema DJ; Rosecrans JA
Pharmacol Biochem Behav; 1984 Jan; 20(1):95-101. PubMed ID: 6420809
[TBL] [Abstract][Full Text] [Related]
47. Effect of p-chloroamphetamine and 5,7-dihydroxytryptamine on rotation and dopamine turnover.
Giambalvo CT; Snodgrass SR
Brain Res; 1978 Jun; 149(2):453-67. PubMed ID: 566608
[TBL] [Abstract][Full Text] [Related]
48. Effects of neonatal treatment with 5,7-dihydroxytryptamine or 6-hydroxydopamine on the ontogenetic development of the audiogenic immobility reaction in the rat.
Hard E; Ahlenius S; Engel J
Psychopharmacology (Berl); 1983; 80(3):269-74. PubMed ID: 6412273
[TBL] [Abstract][Full Text] [Related]
49. Serotonin reuptake inhibitors do not prevent 5,7-dihydroxytryptamine-induced depletion of serotonin in rat brain.
Choi S; Jonak E; Fernstrom JD
Brain Res; 2004 May; 1007(1-2):19-28. PubMed ID: 15064132
[TBL] [Abstract][Full Text] [Related]
50. Endogenous levels of serotonin and 5-hydroxyindoleacetic acid in specific areas of the pigeon CNS: effects of serotonin neurotoxins.
Alesci R; Bagnoli P
Brain Res; 1988 May; 450(1-2):259-71. PubMed ID: 2456822
[TBL] [Abstract][Full Text] [Related]
51. Effect of depletion of brain 5-hydroxytryptamine by 5,7-dihydroxytryptamine on ethanol tolerance and dependence in the rat.
Wood JM
Psychopharmacology (Berl); 1980 Jan; 67(1):67-72. PubMed ID: 6768080
[TBL] [Abstract][Full Text] [Related]
52. Temporal effects of intrahypothalamic 5,7-dihydroxytryptamine: relationship between serotonin levels and [3H]serotonin binding.
Frankfurt M; Allen DL; Luine VN; Beaudet A
Brain Res; 1987 Sep; 419(1-2):216-22. PubMed ID: 2445421
[TBL] [Abstract][Full Text] [Related]
53. Supersensitivity to intrathecal 5-hydroxytryptamine, but not noradrenaline, following depletion of spinal 5-hydroxytryptamine by 5,7-dihydroxytryptamine administered into various sites.
Sawynok J; Reid A
Naunyn Schmiedebergs Arch Pharmacol; 1990 Jul; 342(1):1-8. PubMed ID: 2402297
[TBL] [Abstract][Full Text] [Related]
54. Serotonin turnover and supersensitivity after neonatal 5,7-dihydroxytryptamine.
Mueller RA; Towle A; Breese GR
Pharmacol Biochem Behav; 1985 Feb; 22(2):221-5. PubMed ID: 2580321
[TBL] [Abstract][Full Text] [Related]
55. Responsiveness of cortical neurons to serotonin after 5,7-DHT denervation or PCPA depletion.
Ferron A; Reader TA; Descarries L
J Physiol (Paris); 1981; 77(2-3):381-4. PubMed ID: 6457141
[TBL] [Abstract][Full Text] [Related]
56. 5,7-dihydroxytryptamine-induced mouse killing and behavioral reversal with ventricular administration of serotonin in rats.
Applegate CD
Behav Neural Biol; 1980 Oct; 30(2):178-90. PubMed ID: 7192550
[No Abstract] [Full Text] [Related]
57. The effect of 5,7-dihydroxytryptamine on the serum corticosterone resistance to suppression by dexamethasone.
McIntyre IM; Oxenkrug GF; Stanley M; Gershon S
Brain Res; 1984 Aug; 309(1):156-8. PubMed ID: 6488005
[TBL] [Abstract][Full Text] [Related]
58. Effects of microinjections of 5,7-dihydroxytryptamine in the suprachiasmatic nuclei of the rat on serotonin reuptake and the circadian variation of corticosterone levels.
Williams JH; Miall-Allen VM; Klinowski M; Azmitia EC
Neuroendocrinology; 1983 Jun; 36(6):431-5. PubMed ID: 6877522
[TBL] [Abstract][Full Text] [Related]
59. 5-hydroxy-3-ethylamino-2-oxindole is not formed in rat brain following a neurotoxic dose of methamphetamine: evidence that methamphetamine does not induce the hydroxyl radical-mediated oxidation of serotonin.
Yang Z; Wrona MZ; Dryhurst G
J Neurochem; 1997 May; 68(5):1929-41. PubMed ID: 9109519
[TBL] [Abstract][Full Text] [Related]
60. 5,7-Dihydroxytryptamine lesions of the ascending 5-hydroxytryptamine pathways: habituation, motor activity and agonistic behavior.
Hole K; Johnson GE; Berge OG
Pharmacol Biochem Behav; 1977 Sep; 7(3):205-10. PubMed ID: 563078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
